Rowan Digital Works

MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis, Andrej Spec, John Pullman, George R. Thompson, William G. Powderly, Ellis H. Tobin, Jose Vazquez, Stephen A. Wring, David Angulo, Silvia Helou, Peter G. Pappas, Jose Vasquez, Luis Ostrosky-Zeichner, Thomas Patterson, Barbara Alexander, Helen Boucher, Peter Pappas, Robert Betts, Mindy Schuster, Shmuel Shoham, Sanjay Revankar, David Mushatt, Roger Bedimo, Alison Freifeld, Minh Hong Nguyen, Eleftherios Mylonakis, Daniel Kett, Annette Reboli, Thomas Walsh, Stephanie Pouch, Nikolaos Almyroudis, David Andes, Susan Hadley, Michelle Barron, Katheen Mullane, Loren Miller
Annette C. Reboli